Part D Price Negotiations Still On Ways And Means Committee’s 2007 Agenda
Executive Summary
Even though the House passed legislation that would require HHS to engage in price negotiations for Medicare Part D drugs, price negotiations remain on the House Ways and Means Committee list of Part D-related issues the congressional body plans to examine during the 110th Congress
You may also be interested in...
CMS Price Negotiation Could Tackle High-Cost Drugs, Economists Suggest
Medicare should consider negotiating prices for drugs that are priced high for Part D relative to other selected payers, Johns Hopkins University Professor of Health Policy and Management Gerald Anderson advocated at a Jan. 11 Senate Finance Committee hearing
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.